|
This report is submitted beyond 30-calendar days from allergan¿s receipt due to the exemption transition period.Information contained in this report was previously submitted through 410 psr on 23/oct/17 and 22/apr/2019.A review of the device history record has been completed.No deviations or non-conformances noted.Device evaluation: visual analysis of the returned device identified weight within specification, deformation, and yellow particles.Cloudiness and bubbles were observed after autoclave disinfection process.Based on the device analysis the final assessment is no issues found related with the manufacturing process.The reason for reoperation was capsular contracture, baker grade iv.Further information from the reporter regarding event, product, or patient details has been requested.No additional information is available at this time.This is a known potential adverse event addressed in the product labeling.
|